31.03.2014 Views

in vitro PHARMACOLOGY 2011 CATALOG - Cerep

in vitro PHARMACOLOGY 2011 CATALOG - Cerep

in vitro PHARMACOLOGY 2011 CATALOG - Cerep

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

178 <strong>in</strong> <strong>vitro</strong> pharmacology <strong>2011</strong> catalog<br />

❚ arachidonic acid metabolism<br />

15-lipoxygenase<br />

Source<br />

soybean<br />

Substrate<br />

arachidonic acid (35 µM)<br />

❚ lipoxygenase<br />

Measured product ferric oxidation of xylenol orange<br />

Ref. 0190<br />

Detection method photometry<br />

Q 3 weeks<br />

Reference<br />

NDGA (IC 50 : 1.1 µM)<br />

Included <strong>in</strong>:<br />

Organ safety profile<br />

Waslidge, N.B. and Hayes, D.J. (1995) Anal. biochem., 231: 354-358.<br />

enzyme activity (% of control)<br />

100<br />

50<br />

0<br />

-8 -7 -6 -5 -4<br />

log [drug] (M)<br />

NDGA<br />

COX 1<br />

❚ cyclooxigenase<br />

Ref. 0726<br />

Q 3 weeks<br />

Included <strong>in</strong>:<br />

Non-k<strong>in</strong>ase enzyme profile<br />

BioPr<strong>in</strong>t ® profile<br />

Source<br />

Substrate<br />

Measured product PGE 2<br />

Detection method EIA<br />

Reference<br />

human recomb<strong>in</strong>ant (Sf9 cells)<br />

arachidonic acid (4 µM)<br />

diclofenac (IC 50 : 13 nM)<br />

Glaser, K. et al. (1995) Eur. J. Pharmacol., 281: 107-111.<br />

enzyme activity (% of control)<br />

100<br />

-10 -9 -8 -7 -6 -5 -4<br />

50<br />

-11 -10 -9 -8 -7 -6<br />

-12 -11 -10 -7 -6<br />

-9 -8<br />

diclofenac<br />

0<br />

sul<strong>in</strong>dac<br />

<strong>in</strong>domethac<strong>in</strong>e<br />

-11 -10 -9 -8 -7 -6 -5<br />

log [drug] (M)<br />

COX 2<br />

❚ cyclooxigenase<br />

Ref. 0727<br />

Q 3 weeks<br />

Included <strong>in</strong>:<br />

Non-k<strong>in</strong>ase enzyme profile<br />

BioPr<strong>in</strong>t ® profile<br />

Organ safety profile<br />

Source<br />

human recomb<strong>in</strong>ant (Sf9 cells)<br />

Substrate<br />

arachidonic acid (2 µM)<br />

Measured product PGE 2<br />

Detection method EIA<br />

Reference<br />

NS398 (IC 50 : 68 nM)<br />

Glaser, K. et al. (1995) Eur. J. Pharmacol., 281: 107-111.<br />

enzyme activity (% of control)<br />

100<br />

-10 -9 -8 -7 -6 -5 -4<br />

50 -11 -10 -9 -8 -7 -6<br />

-12 -11 -10 -6<br />

-9 -8 -7<br />

NS 398<br />

diclofenac<br />

rofecoxib<br />

0<br />

<strong>in</strong>domethac<strong>in</strong>e<br />

-10 -9 -8 -7 -6 -5 -4<br />

log [drug] (M)<br />

sPLA 2 (Type V)<br />

❚ phospholipase<br />

Ref. 3176<br />

Q 3 weeks<br />

Included <strong>in</strong>:<br />

Non-k<strong>in</strong>ase enzyme profile<br />

Organ safety profile<br />

Source<br />

Substrate<br />

Measured product<br />

Detection method<br />

human recomb<strong>in</strong>ant (E. coli)<br />

diheptanoyl thio-PC (250 µM)<br />

heptanoyl thio-PC<br />

photometry<br />

Reference<br />

oleyloxyethyl phosphorylchol<strong>in</strong>e<br />

(IC 50 : 20 µM)<br />

Tiege, U.J. et al. (2005) J. Lipid. Res., 46: 1604-1614.<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

sPLA 2 (bee venom type III)<br />

❚ phospholipase<br />

Ref. 2999<br />

Q 3 weeks<br />

Source<br />

Substrate<br />

Measured product<br />

Detection method<br />

Reference<br />

bee venom<br />

diheptanoyl thio-PC (250 µM)<br />

heptanoyl thio-PC<br />

photometry<br />

oleyloxyethyl phosphorylchol<strong>in</strong>e<br />

(IC 50 : 5.7 µM)<br />

Tiege, U.J. et al. (2005) J. Lipid. Res., 46: 1604-1614.<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

TXA 2 synthetase<br />

❚ TXA 2 synthetase<br />

Ref. 0564<br />

Q 3 weeks<br />

Source<br />

human platelets<br />

Substrate<br />

PGH 2 (10 µM)<br />

Measured product TXB 2<br />

Detection method EIA<br />

Reference<br />

furegrelate (IC 50 : 6 nM)<br />

Wade, M.L. and Fitzpatrick, F.A. (1997) Arch. Biochem. Biophys., 347: 174-180.<br />

enzyme activity (% of control)<br />

<br />

100<br />

<br />

<br />

<br />

50<br />

<br />

<br />

0<br />

furegrelate<br />

<br />

<br />

-9 -8 -7 -6 -5<br />

-11 -10<br />

log [drug] (M)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!